Network pharmacology reveals potential targets and mechanisms of Rhizoma Chuanxiong for diabetic kidney disease.
Background Although Rhizoma Chuanxiong has been used for the treatment of diabetic kidney disease (DKD), the relevant mechanisms remain unclear. The purpose of this study was to investigate the potential targets and mechanisms of Rhizoma Chuanxiong in treating DKD, utilizing network pharmacology.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: